Factors Associated with Thyroid Malignancy among Patients Presenting with Thyroid Nodule

Authors

  • Razia Anwar Department of ENT, Sandamen Provincial Hospital, Quetta, Pakistan
  • Asmat Ullah Department of ENT, Sandamen Provincial Hospital, Quetta, Pakistan
  • Firasat Ullah Shah Department of Medicine, Mir Gul Khan Naseer Teaching Hospital, Nushki, Pakistan
  • Kaleem Ullah Department of ENT, Sandamen Provincial Hospital, Quetta, Pakistan
  • Ammara Arbab Department of ENT, Sandamen Provincial Hospital, Quetta, Pakistan
  • Sohail Khan Department of ENT, Sandamen Provincial Hospital, Quetta, Pakistan
  • Afzal Khan Department of ENT, Sandamen Provincial Hospital, Quetta, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v3i7.2465

Keywords:

Thyroid nodule; thyroid malignancy; risk factors; case–control; TSH; obesity; radiation exposure; Pakistan

Abstract

Background: Thyroid nodules are increasingly detected worldwide, and while most are benign, a meaningful proportion harbor malignancy. Regional differences in incidence and mortality suggest contributions from demographic, environmental, and clinical factors—underscoring the need for context-specific risk assessment. Objective: To determine the clinical and demographic factors associated with malignancy among patients presenting with thyroid nodules. Methods: We will conduct a case–control study in the Department of ENT, Bolan Medical College/Hospital, Quetta, over six months following ethical approval. Using non-probability consecutive sampling, 110 participants will be enrolled (55 malignant, 55 benign). Malignancy will be confirmed on histopathology. Candidate factors include female gender, obesity (BMI ≥30 kg/m²), raised TSH (>4.5 mIU/L), comorbidity (diabetes, hypertension, COPD or asthma), family history of thyroid malignancy, prior radiation exposure, and recent increase in neck swelling; additional variables captured are age, residence, smoking, nodule size, and duration. Data will be analyzed in SPSS v26 using binary logistic regression to estimate crude and adjusted odds ratios (95% CI). Variables with p<0.25 on invariable analysis will enter multivariable modeling; retention will be based on clinical relevance or p<0.10, with effect modifiers controlled in the final model. Expected Impact: By identifying independent predictors of thyroid malignancy among patients with nodules in our setting, this study aims to inform local risk stratification, guide diagnostic decision-making, and highlight modifiable factors for targeted prevention.

Downloads

Download data is not yet available.

References

1. Zheng, T., Wang, L., Wang, H., et al. (2024). Prediction model based on MRI morphological features for distinguishing benign and malignant thyroid nodules. BMC Cancer, 24, 256.

https://doi.org/10.1186/s12885-024-11995-3

2. Cotter, A., & Jinih, M. (2025). Thyroid nodule size and risk of malignancy: a systematic review. Discover Oncology, 16(1), 1188.

https://doi.org/10.1007/s12672-025-02588-y

3. Wan, Z., Li, Y., Dong, X., Kang, Y., Luo, J., Wang, J., & Cheng, A. S. (2023). Influence of metabolic syndrome and lifestyle factors on thyroid nodules in Chinese adult men: a cross-sectional study. European thyroid journal, 12(6).

https://doi.org/10.1530/etj-23-0168

4. Smit, E. J., Samadi, S., Wilson, M. P., & Low, G. (2024). Cancer risk in thyroid nodules: An analysis of over 1000 consecutive FNA biopsies performed in a single canadian institution. Diagnostics, 14(24), 2775.

https://doi.org/10.3390/diagnostics14242775

5. Rehman, A. U., Ehsan, M., Javed, H., Ameer, M. Z., Mohsin, A., Aemaz Ur Rehman, M., ... & Ameer, F. (2022). Solitary and multiple thyroid nodules as predictors of malignancy: a systematic review and meta-analysis. Thyroid Research, 15(1), 22.

https://doi.org/10.1186/s13044-022-00140-6

6. Kim, D. H., Kim, S. W., Basurrah, M. A., Lee, J., & Hwang, S. H. (2023). Diagnostic performance of six ultrasound risk stratification systems for thyroid nodules: a systematic review and network meta-analysis. American Journal of Roentgenology, 220(6), 791-803.

https://doi.org/10.2214/ajr.22.28556

7. David, E., Grazhdani, H., Tattaresu, G., Pittari, A., Foti, P. V., Palmucci, S., ... & Basile, A. (2024). Thyroid nodule characterization: Overview and state of the art of diagnosis with recent developments, from imaging to molecular diagnosis and artificial intelligence. Biomedicines, 12(8), 1676.

https://doi.org/10.3390/biomedicines12081676

8. Rebelo, J. F. D., Costa, J. M., Junqueira, F. D., Fonseca, A. D. O., de Almeida, A. B. A. B. S., Moraes, A. B., & Vieira Neto, L. (2023). Adrenal incidentaloma: Do patients with apparently nonfunctioning mass or autonomous cortisol secretion have similar or different clinical and metabolic features?. Clinical Endocrinology, 98(5), 662-669.

https://doi.org/10.1111/cen.14861

9. Himuro, M., Miyatsuka, T., Suzuki, L., Miura, M., Katahira, T., Goto, H., ... & Watada, H. (2019). Cellular autophagy in α cells plays a role in the maintenance of islet architecture. Journal of the Endocrine Society, 3(11), 1979-1992.

https://doi.org/10.1210/js.2019-00075

10. Kamran, S. C., Marqusee, E., Kim, M. I., Frates, M. C., Ritner, J., Peters, H., ... & Alexander, E. K. (2013). Thyroid nodule size and prediction of cancer. The Journal of Clinical Endocrinology & Metabolism, 98(2), 564-570.

https://doi.org/10.1210/jc.2012-2968

11. Boonrod, A., Akkus, Z., Castro, M. R., Zeinodini, A., Philbrick, K., Stan, M., & Erickson, B. (2021). Thyroid nodule size as a predictor of malignancy in follicular and Hurthle neoplasms. Asian Pacific journal of cancer prevention: APJCP, 22(8), 2597.

https://doi.org/10.31557/apjcp.2021.22.8.2597

12. Savage, S. A., Gadalla, S. M., & Chanock, S. J. (2013). The long and short of telomeres and cancer association studies. Journal of the National Cancer Institute, 105(7), 448-449.

https://doi.org/10.1093/jnci/djt041

13. Li, J., Li, C., Zhou, X., Huang, J., Yang, P., Cang, Y., ... & Liang, P. (2023). US risk stratification system for follicular thyroid neoplasms. Radiology, 309(2), e230949.

https://doi.org/10.1148/radiol.230949

14. Tang, P., Ren, C., Shen, L., & Zhou, Z. (2021). Development and validation of a diagnostic nomogram for preoperative differentiation between follicular thyroid carcinoma and adenomas. Journal of Computer Assisted Tomography, 45(1), 128–134.

https://doi.org/10.1097/rct.0000000000001078

15. Cao, Y., Yang, Y., Chen, Y., Luan, M., Hu, Y., Zhang, L., ... & Zhou, W. (2024). Optimizing thyroid AUS nodules malignancy prediction: a comprehensive study of logistic regression and machine learning models. Frontiers in Endocrinology, 15, 1366687.

https://doi.org/10.3389/fendo.2024.1366687

16. Le, Y., Geng, C., Gao, X., & Zhang, P. (2024). The risk of thyroid cancer and sex differences in Hashimoto’s thyroiditis, a meta-analysis. BMC Endocrine Disorders, 24(1), 151.

https://doi.org/10.1186/s12902-024-01670-w

17. Zhang, X., Fan, H., Yu, Q., Tong, X., Rao, X., Tang, T., & Cheng, Y. (2025). Global burden of thyroid cancer attributed to high body mass index and predictive trends: estimated results from the global health data study, 1990–2021. Thyroid Research, 18(1), 43.

https://doi.org/10.1186/s13044-025-00260-9

18. Durmała, K., Pyc, G., Bęben, D., Kowalewski, J., Mączka, J., Dąbrowska, A., ... & Pakos, K. (2024). Correlation between selenium levels and thyroid cancer–a literature review. Journal of Pre-Clinical and Clinical Research, 18(4), 345-352.

https://doi.org/10.26444/jpccr/195942

19. Ahmed, F., Abbasi, L., Ghouri, N., & Patel, M. J. (2022). Epidemiology of in-hospital cardiac arrest in a Pakistani tertiary care hospital pre-and during COVID-19 pandemic. Pakistan Journal of Medical Sciences, 38(2), 387.

https://doi.org/10.12669/pjms.38.icon-2022.5776

20. Lim, J., Garigipati, P., Liu, K., Johnson, R. F., & Liu, C. (2023). Risk factors for post‐tonsillectomy respiratory events in children with severe obstructive sleep apnea. The Laryngoscope, 133(5), 1251-1256.

https://doi.org/10.1002/lary.30317

21. Abrishami, G., Emadzadeh, M., Bakhshi, A., et al. (2025). Metabolic syndrome predicts thyroid nodules: Cross-sectional study in Iranian adults. BMC Endocrine Disorders, 25, 40.

https://doi.org/10.1186/s12902-025-01869-5

22. Koc, G., Yilmaz, R., Canatalay, S., et al. (2025). Malignancy risk in thyroid nodules with ultrasonographic thyroid capsule expansion. Thyroid, 35(5), 501–508.

23. Wang, L., Zhao, J., Liu, H., et al. (2023). Subclinical hypothyroidism increases risk of extrathyroidal extension in papillary thyroid carcinoma. Frontiers in Endocrinology, 14, 1294441.

24. Yousefi, M., Farabi Maleki, S., Jafarizadeh, A., et al. (2024). Artificial intelligence and radiomics in thyroid cancer diagnosis: A PRISMA-based review. arXiv Preprint, arXiv:2404.07239.

https://arxiv.org/abs/2404.07239

25. Xi, N., Wang, L., & Yang, C. (2022). Machine learning improves preoperative thyroid cancer diagnosis. arXiv Preprint, arXiv:2203.15804.

https://arxiv.org/abs/2203.15804.

Downloads

Published

2025-07-14

How to Cite

Anwar, R., Asmat Ullah, Shah, F. U., Kaleem Ullah, Arbab, A., Khan, S., & Khan, A. (2025). Factors Associated with Thyroid Malignancy among Patients Presenting with Thyroid Nodule. Indus Journal of Bioscience Research, 3(7), 1210-1215. https://doi.org/10.70749/ijbr.v3i7.2465